INTRADAY SANOFICONR.NS Sanofi CH (NSE) 4,179.80 Feb 2026 earnings: watch margins

SANOFICONR.NS stock trades at INR 4,179.80 on the NSE in intraday trade on 18 Feb 2026, down 0.93% today as the market prices in tomorrow’s earnings release (19 Feb 2026). Investors will watch gross and operating margin swings in the consumer healthcare portfolio, where volumes and trade promotions can swing quarterly profits. With a trailing PE of 44.08 and EPS of 94.82, the report will be a near-term catalyst for price direction and analyst revisions.

Earnings preview: SANOFICONR.NS stock

Sanofi Consumer Healthcare India will report results on 19 Feb 2026 and the market expects margin clarity. Last twelve months metrics show net income per share INR 94.61 and a net profit margin of 26.96%, so the focus is on revenue mix and cost of goods sold. One clear near-term driver is whether rebate and trade promotion costs compress gross margin more than marketing-led volume gains.

Revenue and margin levers in the report

SANOFICONR.NS earnings hinge on three levers: branded OTC demand, institutional sales, and promotional intensity. The company’s revenue per share INR 350.86 and gross profit margin 69.51% give buffer, but higher promotional spend or channel discounts can cut operating margin quickly. Analysts will watch segment commentary on Allegra, Combiflam and Festal for signs of sustainable volume recovery.

Valuation and fundamentals: SANOFICONR.NS analysis

On fundamentals SANOFICONR.NS stock shows strong balance-sheet metrics: cash per share INR 94.65, book value per share INR 111.58, and debt to equity 0.11. Valuation is rich versus peers with P/E 44.08, P/S 11.91, and P/B 37.46. Return on equity at 82.23% and interest coverage 136.05 highlight profitability, but high price multiples increase sensitivity to any earnings miss.

Technical and trading context for intraday moves

Intraday technicals show the stock trading between a day low INR 4,160.10 and day high INR 4,224.50 with low volume 2,361 shares so far. RSI sits at 50.84, Bollinger middle at INR 4,187.46 and ATR INR 136.63, suggesting normal intraday volatility. Traders should note average volume 3,727 and a positive MACD histogram signaling short-term momentum if earnings beat expectations.

Meyka grade, forecast and price targets

Meyka AI rates SANOFICONR.NS with a score out of 100: 69.18 / 100 | Grade: B | Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects monthly INR 4,464.64, quarterly INR 4,632.55 and yearly INR 4,304.56. These are model-based projections and not guarantees. For a practical trading frame, analyst-conservative price target near INR 4,300.00 and upside target on a beat at INR 4,650.00 are reasonable short-term anchors.

Risks and catalysts for SANOFICONR.NS stock

Key upside catalysts are stronger-than-expected volume growth, margin expansion, or favourable channel mix. Downside risks include higher promotional spend, regulatory price pressure, or macro weakness hitting retail demand. Liquidity is thin; low daily volume raises execution risk around the earnings print. Monitor management commentary on pricing and trade terms carefully.

Final Thoughts

SANOFICONR.NS stock is priced at INR 4,179.80 as markets enter an earnings-sensitive window on 19 Feb 2026. Meyka AI’s forecast model projects monthly INR 4,464.64, quarterly INR 4,632.55, and yearly INR 4,304.56. Versus the current price this implies a model-based upside of 6.82% (monthly), 10.83% (quarterly) and 2.99% (yearly). Valuation is elevated with a trailing P/E 44.08 and P/B 37.46, making the stock vulnerable to an earnings miss but likely to rally on margin beats. Our Meyka grade (B, HOLD) reflects balanced fundamentals and elevated multiples. Traders should size positions for low liquidity, watch management guidance on promotions, and use conservative stop-losses into the print. Forecasts are model-based projections and not guarantees.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.